跳到正文
原文
Nature 健康护理主题·· 14 天前AI 评分46

1994-2024年先天性心脏病患者一年生存率和终止妊娠趋势分析:基于人群注册研究

Trends in one-year survival and pregnancy termination in congenital heart defects in 1994–2024: a population-based registry

AI 导读

研究分析了1994年至2024年间5898例先天性心脏病患者的生存率和终止妊娠的趋势。总体生存率有所提高,尤其是在严重孤立性先天性心脏病患者中。终止妊娠率在孤立性先天性心脏病患者中下降。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

To assess trends in one-year survival among infants with congenital heart defects (CHD) and in termination of pregnancy for fetal anomaly (TOPFA), with particular attention to isolated and severe isolated CHD. 5,898 CHD from the Paris Registry of Congenital Anomalies (1994–2024) were included. Isolated CHD were defined as CHD without associated genetic or extracardiac anomalies, as opposed to non-isolated CHD. One-year survival was estimated using Kaplan–Meier methods. Temporal trends in survival and TOPFA among pregnancies with a recorded prenatal diagnosis of CHD, were analyzed using logistic regression. Non-linearity (fractional polynomials) and slope changes (segmented models) were assessed. Among 5,898 CHD cases, 4,391 were live births, 1,361 TOPFA and 146 stillbirths. One-year survival was 91.0% (95% CI 90.1–91.8), reaching 95.0% (95% CI 94.2–95.7) in isolated CHD and 84.0% (95% CI 81.4–86.2) in severe isolated CHD. Overall survival improved significantly over time (p < 0.001), with a change in slope around 2007–2009; the absolute annual gain decreased from approximately + 0.5% (95% CI 0.26–0.68) at the beginning of the study period to + 0.2% (95% CI 0.16–0.23) in recent years. Similar improvement was observed in isolated CHD, with smaller gains after approximately 2009, and in severe isolated CHD (+ 0.56% per year; 95% CI 0.28–0.84). Among prenatally diagnosed pregnancies, TOPFA decreased in isolated CHD (− 0.50% per year; 95% CI − 0.74 to − 0.26) and severe isolated CHD (− 0.36%; 95% CI − 0.69 to − 0.03). One-year survival improved over three decades, although gains became smaller over time rather than showing a uniform plateau across CHD subgroups. Improvement extended to severe isolated CHD and occurred alongside declining TOPFA among prenatally diagnosed isolated and severe isolated CHD.

Abbreviations

CHD:

Congenital Heart Defect

EUROCAT:

European Surveillance of Congenital Anomalies

ICD:

International Classification of Disease

REMAPAR:

Paris Registry of Congenital Anomalies

TOPFA:

Termination of Pregnancy for Fetal Anomaly

VSD:

Ventricular Septal Defects

Acknowledgements

We thank all department heads and services in Paris for their participation in the collection of data used in this analysis.

Funding

The Paris Registry of Congenital Anomalies (REMAPAR) receives financial support from INSERM and Santé publique France. This study was funded by the Fédération Française de Cardiologie.

Author information

Author notes

  1. These authors contributed equally: Neil Derridj and Isabelle Monier.

Authors and Affiliations

  1. Centre for Research in Epidemiology and Statistics, Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, 75004, Paris, France

    Neil Derridj, Isabelle Monier, Marine Wojciechowski, François Goffinet, Nathalie Lelong & Babak Khoshnood

  2. M3C-Pediatric Cardiology, Necker Enfants Malades, AP-HP, University of Paris Cité, Paris, France

    Neil Derridj & Damien Bonnet

Authors

  1. Neil Derridj
  2. Isabelle Monier
  3. Marine Wojciechowski
  4. François Goffinet
  5. Damien Bonnet
  6. Nathalie Lelong
  7. Babak Khoshnood

Corresponding author

Correspondence to Isabelle Monier.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki.

Consent to participate

In accordance with French regulations, participants were informed of the collection and use of their data and could exercise their right to object.

Role of the funder

The funders had no role in the design, conduct, analysis, interpretation of the data, or decision to submit the manuscript.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Derridj, N., Monier, I., Wojciechowski, M. et al. Trends in one-year survival and pregnancy termination in congenital heart defects in 1994–2024: a population-based registry. Sci Rep (2026). https://doi.org/10.1038/s41598-026-78475-5

Download citation

  • Received: 22 June 2026

  • Accepted: 26 October 2026

  • Published: 06 November 2026

  • DOI: https://doi.org/10.1038/s41598-026-78475-5

Keywords

来源:Nature 健康护理主题 · nature.com